Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elisa Schettino
Institution:
University of Naples Federico II
Observed institutions:
Federico II University Hospital,
University of Naples Federico II
ORCID:
0009-0006-0684-2024
Observed ORCID:
0009-0006-0684-2024
OpenAlex ID:
A5078630788
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study
2022
·
Biagio Pinchera
, Lorenzo Spirito
, et al.
·
Frontiers in Medicine
·
16
PDF
BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients
2023
·
Evelina La Civita
, Carla Zannella
, et al.
·
Viruses
·
9
PDF
Urinary tract infections in kidney transplant patients admitted to hospital: A real-life experience
2025
·
Biagio Pinchera
, Elisa Schettino
, et al.
·
World Journal of Transplantation
·
4
PDF
Bulevirtide Treatment of Hepatitis Delta Virus Infection in a Kidney Transplant Recipient: A Case Report.
2024
·
Biagio Pinchera
, Rosa Carrano
, et al.
·
Experimental and Clinical Transplantation
·
4
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Series
2023
·
Biagio Pinchera
, Rosa Carrano
, et al.
·
OBM Transplantation
PDF
Pre-exposure prophylaxis for COVID-19 with Tix-agevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience
2023
·
Biagio Pinchera
, Rosa Carrano
, et al.
·
Preprints.org
PDF
Show more works
View as search
Works count:
6
Citation count:
33
H-index:
4
I10-index:
1
Year
Topic
Type